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Abstract
Chronic kidney disease (CKD) is characterized by increased risks of morbidity and mortality. Upper-body subcutaneous fat, which is
commonly estimated from the neck circumference (NC), was revealed to be the main reservoir of circulating nonesteriﬁed fatty acids
in overweight patients. Despite a close association between NC and metabolic complications, the relationship of NC with renal
function has not been fully investigated. In this study, the impact of NC on the development of incident CKD was elucidated.
The data were retrieved from the Korean Genome and Epidemiology Study cohort. The subjects were followed at 2-year intervals
from 2003 to 2011. Overweight was deﬁned as a body mass index of ≥23kg/m2. A total of 4298 cohort subjects were screened.
After exclusion, 2268 overweight subjects were included for the ﬁnal analysis. The primary end point was incident CKD, which was
deﬁned as a composite of estimated glomerular ﬁltration rate (eGFR)<60mL/min/1.73m2 or the development of proteinuria.
Themean patient agewas 36.3±3.0 years, and 1285 (56.7%) weremen. They were divided into 2 groups according to themedian
NC in male and female subjects, separately. In both sexes, hypertension (men, P<0.001; women, P=0.009) and diabetes (men, P=
0.002; women, P<0.001) were signiﬁcantly more prevalent in the big NC group than in the small NC group. In contrast, eGFR was
signiﬁcantly lower only in male subjects of the big NC group (P<0.001), whereas it was comparable between the small and big NC
groups (P=0.167). In multivariate Cox proportional hazards regression analysis, NC values were independently associated with
incident CKD development in female subjects after adjusting for multiple confounding factors (per 1cm increase, hazard ratio [95%
conﬁdence interval]=1.159 [1.024–1.310], P=0.019) but not in male subjects.
NC is independently associated with the development of CKD in overweight female subjects, suggesting that it could be a practical
risk factor for CKD.
Abbreviations: BMI = body mass index, CKD = chronic kidney disease, eGFR = estimated glomerular ﬁltration rate, hs-CRP =
high-sensitivity C-reactive protein, NC = neck circumference, NEFA = nonesteriﬁed fatty acid, VAT = visceral adipose tissue.
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1. Introduction decline in renal function, identiﬁcation of patients at risk may beChronic kidney disease (CKD) is characterized by increased risks
of morbidity andmortality.[1] Owing to continuous and relentlessEditor: Ikechi Okpechi.
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1crucial for reducing the burden of CKD.[2]
Overweight is a well-known predictor of cardiovascular events
and mortality. It was also demonstrated that overweight persons
were at a greater risk for a rapid decline in renal function.[3] In
addition, longitudinal studies found that there was a close
association between adiposity and incident CKD in the general
population regardless of age or baseline renal function.[4] Among
a variety of fat tissues, visceral adipose tissue (VAT) was revealed
to be the main pathogenic source of fat responsible for metabolic
derangements in overweight patients.[5] The amount of VAT in
overweight patients showed close relationships with insulin
resistance, type 2 diabetes, and atherosclerosis.[6,7] However, the
association between VAT and kidney diseases was not
consistently reported, suggesting that some other fat tissues
rather than VAT may play key roles in the pathogenesis of the
decline in renal function in overweight patients.
Upper-body subcutaneous fat, which is commonly estimated
from the neck circumference (NC),[8–10] has recently been
demonstrated to be the main reservoir of circulating nonesteriﬁed
fatty acids (NEFAs) in overweight patients.[11] Moreover,
previous studies found that NEFA concentrations were closely
related to insulin resistance and endothelial dysfunction,
implying that upper-body subcutaneous fat, besides VAT, could
be an important modulator of cardiometabolic risks in obese
[12,13]
Figure 1. Flow diagram of the study, BMI=body mass index, CKD=chronic
kidney disease.
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NC was more signiﬁcantly associated with cardiometabolic risk
factors than the body mass index (BMI) or waist circumference,
further supporting this notion.[10,14] To date, however, the
relationship of NC with renal function has not been fully
investigated.
In this study, the impact of NC, a representative of upper-body
subcutaneous fat, on the development of incident CKD was
elucidated in Korean overweight subjects who participated in a
community-based prospective cohort study.2. Methods
2.1. Study population
The present study was performed by using the data from the
KoreanGenome and Epidemiology Study (KoGES), a prospective
community-based cohort study. The study cohort consisted of
40- to 69-year-old residents of Ansan or Ansung City, a city
nearby the capital city Seoul. Assessment was conducted
biennially from 2003 to 2011. Subjects who had missing data
or CKD at baseline and were not overweight or obese based on
the World Health Organization Asian criteria (BMI<23kg/m2)
were excluded. Thus, a total of 2268 subjects were included in the
ﬁnal analysis (Fig. 1).
This study was carried out in accordance with the Declaration
of Helsinki and approved by the institutional review board of
Yonsei University Health System Clinical Trial Center.
2.2. Data collection
A comprehensive health examination was done, and question-
naires on health and lifestyle were ﬁlled out by all participants at
the time of study entry. With the subjects wearing light clothes,
their height, body weight, waist and hip circumference, and NC
were measured by experienced research workers through
standard methods. The BMI and waist-to-hip ratio were
calculated as weight/height (kg/m2) and waist/hip circumference,
respectively. Demographic data including age, sex, comorbid-
ities, alcohol intake, smoking, and exercise were also collected.
Subjects who had a blood pressure >140/90mmHg or were
taking antihypertensive medications were considered hyperten-
sive, and those who had a fasting glucose concentration of ≥126
mg/dL or a postload glucose concentration of ≥200mg/dL after
the 75-g oral glucose tolerance test, or were receiving treatment
for hyperglycemia were considered diabetic. Cardiovascular
disease was deﬁned as a history of arrhythmia, coronary artery or
peripheral artery disease, or cerebrovascular disease.2Laboratory data were measured by using fasting blood
samples. The following biochemical data were determined with
a 747 Chemistry Analyzer (Hitachi, Tokyo, Japan): concen-
trations of blood glucose, blood urea nitrogen, serum creatinine,
total cholesterol, triglyceride, and high-density lipoprotein
cholesterol, whereas low-density lipoprotein cholesterol was
calculated on the basis of the Friedewald formula.[15] Urine
samples were collected in the morning after the ﬁrst voiding.
Urinalysis was performed on fresh urine samples by physicians,
by using URISCAN Pro II (YD Diagnostics Corp., Seoul, Korea).
The urine test strip results were based on a color scale that
quantiﬁed proteinuria as absent, trace, 1+, 2+, or 3+. This scale
correlated approximately with proteinuria of <10, 10–20, >30,
>100, and >500mg/dL, respectively.[16] The presence of
proteinuria was deﬁned as a urinalysis result higher than the
trace level, and the estimated glomerular ﬁltration rate (eGFR)
was calculated by using the 4-variable Modiﬁcation of Diet in
Renal Disease equation including age, sex, race, and serum
creatinine levels.
2.3. Outcome measure
The primary end point was incident CKD, which was deﬁned as a
composite of eGFR <60mL/min/1.73m2 or the development of
proteinuria during the follow-up period.
2.4. Statistical analysis
Statistical analysis was performed by using IBM SPSS software for
Windows version 23.0 (IBM Corporation, Armonk, NY).
Continuous variables are expressed as mean± standard deviation
or median (interquartile range), and categorical variables as
number (percentage). The normality of the distribution of
the measured parameters was ascertained by using the
Kolmogorov–Smirnov test.Thepatientsweredivided into2groups
based on the median value of NC (37.6cm in men and 32.7cm in
women), and the differences between the 2 groups were analyzed
by using Student t test or theMann–WhitneyU test for continuous
variables, and the Chi-square test for categorical variables.
Univariate and multivariate linear regression analyses were
performed to determine the signiﬁcant factors associated with
NC. Because of the log-normal distributions of serum triglyceride
and high-sensitivity C-reactive protein (hs-CRP) concentrations,
natural log values were used in the analysis. Variables with a
P value of <0.2 in the univariate linear regression analysis were
included in multivariate linear regression analysis. Kaplan–Meier
analysis was performed to determine the impact of NC on the
development of CKD, and between-group difference was
compared by using a log-rank test. The independent predictive
value of NC for incident CKD was ascertained with multivariate
Cox proportional hazards regression analysis. P values <0.05
were considered statistically signiﬁcant.3. Results
3.1. Baseline characteristics
The baseline characteristics of the patients are shown in Table 1.
The mean age was 50.6±7.6 years; 1285 patients (56.7%) were
men; and the mean eGFR was 72.1±7.8mL/min/1.73m2. The
mean values of NCwere 36.3±3.0, 38.4±1.8, and 33.6±1.6cm
in total, male, and female subjects, respectively. In both sexes,
hypertension (men, 108 [17.7%] vs 63 [10.3%], P<0.001;
women, 73 [16.9%] vs 56 [11.0%], P=0.009) and diabetes
Table 1
Baseline characteristics of the study subjects (N=2268).
Variables Total
Men (n=1285, 56.7%)
P
Women (n=983, 43.3%)
PLow NC High NC Low NC High NC
NC, cm 36.3±3.0 37.0±1.1 39.8±1.2 <0.001 32.4±0.9 34.9±1.2 <0.001
Age, years 50.6±7.6 50.3±7.5 49.9±7.0 0.311 51.0±7.8 51.6±8.1 0.267
Alcohol, % 1267 (55.9) 476 (77.5) 481 (79.0) 0.537 164 (32.3) 146 (33.9) 0.620
Smoking, % 959 (42.3) 467 (76.1) 469 (77.0) 0.694 12 (2.4) 11 (2.6) 0.885
Exercise (no, %) 920 (40.6) 260 (42.3) 256 (42.0) 0.913 218 (43.0) 186 (43.2) 0.961
Hypertension, % 300 (13.2) 63 (10.3) 108 (17.7) <0.001 56 (11.0) 73 (16.9) 0.009
Diabetes mellitus, % 166 (7.3) 41 (6.7) 72 (11.8) 0.002 12 (2.4) 41 (9.5) <0.001
History of CVD, % 28 (1.2) 6 (1.0) 9 (1.5) 0.426 7 (1.4) 6 (1.4) 0.988
SBP, mmHg 113.9±16.9 113.8±17.2 117.9±15.4 <0.001 108.4±17.6 114.8±15.7 <0.001
DBP, mmHg 76.6±12.0 70.8±12.4 80.5±11.0 <0.001 71.4±11.8 75.7±11.0 <0.001
Body mass index, kg/m2 25.8±2.1 24.8±1.4 26.7±2.0 <0.001 24.9±1.5 27.2±2.6 <0.001
Waist-to-hip ratio 0.87±0.06 0.90±0.04 0.92±0.04 <0.001 0.82±0.05 0.85±0.05 <0.001
BUN, mg/dL 15.1±4.3 16.0±5.5 15.6±3.5 0.121 14.1±3.6 14.2±3.3 0.773
Creatinine, mg/dL 0.98±0.14 1.07±0.10 1.10±0.09 <0.001 0.85±0.07 0.86±0.07 0.242
eGFR, mL/min/1.73m2 72.1±7.8 74.0±8.2 71.9±7.3 <0.001 71.2±7.5 70.5±7.5 0.167
WBC, 1000 cells/mL 6.08±1.67 6.14±1.65 6.54±1.76 <0.001 5.44±1.41 6.14±1.64 <0.001
Hemoglobin, g/dL 13.9±1.6 14.7±1.0 15.0±1.0 <0.001 12.5±1.1 12.7±1.2 0.001
Fasting plasma glucose, mg/dL 94.2±17.3 94.7±15.6 98.7±20.2 <0.001 90.0±10.8 93.7±19.7 <0.001
Total cholesterol, mg/dL 202.1±33.4 198.4±31.9 202.4±33.0 0.029 202.4±35.4 206.7±32.9 0.052
Triglyceride, mg/dL 143.4±84.8 127 (92–173) 152 (108–211) <0.001
∗
97 (69–132) 121 (87–170) <0.001
∗
HDL-C, mg/dL 45.3±8.9 44.8±8.7 42.9±8.0 <0.001 48.4±9.7 45.8±8.6 <0.001
LDL-C, mg/dL 128.1±31.0 124.3±31.0 124.8±31.6 0.786 131.8±30.9 133.8±29.1 0.294
hs-CRP, mg/L 0.69 (0.39–1.32) 0.64 (0.37–1.21) 0.84 (0.48–1.59) <0.001
∗
0.57 (0.30–1.14) 0.98 (0.43–1.52) <0.001
∗
Variables are expressed as median (range), mean± standard deviation, or n (%). CVD is deﬁned as a history of myocardial infarction, coronary artery disease, peripheral artery disease, and ischemic stroke. BUN=
blood urea nitrogen, CVD= cardiovascular disease, DBP=diastolic blood pressure, eGFR= estimated glomerular ﬁltration rate, HDL-C=high-density lipoprotein cholesterol, hs-CRP=high sensitivity C-reactive
protein, LDL-C= low-density lipoprotein cholesterol, NC=neck circumference, SBP= systolic blood pressure, WBC=white blood cell.
∗
Mann–Whitney U test.
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12 [2.4%], P<0.001) were signiﬁcantly more prevalent in the big
NC group than in the small NC group. Systolic blood pressure,
diastolic blood pressure, BMI, waist-to-hip ratio, white blood cell
count, and hemoglobin, fasting blood glucose, and serum
triglyceride and hs-CRP levels were also signiﬁcantly higher in
the big NC group in both male and female subjects. In contrast,
serum creatinine (1.10±0.09 vs 1.07±0.10mg/dL, P<0.001)
and total cholesterol concentrations (202.4±33.0 vs 198.4±
31.9mg/dL, P=0.029) were signiﬁcantly higher in the big NC
group, only in the male sex group.
3.2. Independent factors associated with NC
Multivariate linear regression analysis revealed that there were
signiﬁcant positive relationships of NC with the presence of
diabetes (b=0.782, P=0.001), BMI (b=0.574, P<0.001),
white blood cell count (b=0.062, P=0.006), fasting blood
glucose (b=0.006, P=0.015), and serum hs-CRP levels (b=
0.152, P<0.001), whereas NC was signiﬁcantly and inversely
correlated with eGFR (b=0.017, P=0.001) in male subjects. In
the female sex group, NC was signiﬁcantly associated with
diabetes (b=0.674, P=0.010), BMI (b=0.367, P<0.001),
waist-to-hip ratio (b=0.360, P<0.001), white blood cell count
(b=0.097, P=0.001), serum triglyceride (b=0.204, P=0.028),
and hs-CRP concentrations (b=0.158, P<0.001), whereas there
was a signiﬁcant inverse correlation between NC and age (b=
0.022, P<0.001) (Table 2).
3.3. Development of incident CKD
During a mean follow-up duration of 95.4±27.6 months in male
subjects and 78.3±28.0 months in female subjects, incident CKD3events were observed in 243 (18.9%) and 212 (21.6%) subjects
in the male and female sex groups, respectively.3.4. Relationship between NC and incident CKD
development
NCwas signiﬁcantly greater in incident CKD subjects than in the
non-CKD group in both sex groups (incident CKD vs non-CKD
group: men, 38.6±1.8 vs 38.3±1.8cm, P=0.016; women, 33.8
±1.8 vs 33.5±1.6cm, P=0.004) (Fig. 2A, B). When the
incidence of newly developed CKD was compared between the
big and small NC groups, CKD events were signiﬁcantly and
more frequently observed in the big NC group relative to the low
NC group in both male and female subjects (big NC vs small NC
group: men, 176 [20.3%] vs 67 [16.0%], P=0.016; women, 162
[23.9%] vs 50 [16.3%], P=0.004) (Fig. 2C).
3.5. Impact of NC on the development of incident CKD
Kaplan–Meier analysis revealed that the big NC group had a
signiﬁcantly worse CKD-free survival rate than the low NC group
in female patients (P<0.001). In contrast, there was no signiﬁcant
difference in the rate of CKD development between the groups in
male patients (P=0.134) (Fig. 3). In Cox proportional hazards
analysis, the NC value was a signiﬁcant risk factor for incident
CKDevents in the female sex group (per1cm increase, hazard ratio
[HR]=1.159, conﬁdence interval [CI]=1.024–1.310, P=0.019)
even after adjusting for confounding factors, whereas the
relationship between the NC value and incident CKD events
was not signiﬁcant inmale subjects (per 1cm increase,HR=0.989,
CI=0.887–1.103, P=0.841) (Table 3, Supplementary Tables 1
and 2, http://links.lww.com/MD/B258). However, the signiﬁcant
Table 2
Association of clinical and biochemical variables with neck circumference.
Variables
Men Women
b P b P
Age (per 1 year) 0.004 0.456 0.022 <0.001
Smoking (yes) 0.171 0.053 0.187 0.453
Hypertension (yes) 0.160 0.169 0.194 0.120
Diabetes mellitus (yes) 0.782 0.001 0.647 0.010
Body mass index (per 1 kg/m2) 0.574 <0.001 0.367 <0.001
Waist-to-hip ratio (per 0.1) 0.012 0.907 0.360 <0.001
eGFR (per 1mL/min/1.73m2) 0.017 0.001 0.010 0.056
White blood cell (per 1000cells/mL) 0.062 0.006 0.097 0.001
Hemoglobin (per 1g/dL) 0.074 0.060 0.017 0.642
Fasting plasma glucose (per 1mg/dL) 0.006 0.015 0.001 0.772
Triglyceride (per 1 log)
∗
0.060 0.460 0.204 0.028
hs-CRP (per 1 log)
∗
0.152 <0.001 0.158 0.002
eGFR= estimated glomerular ﬁltration rate, hs-CRP=high sensitivity C-reactive protein.
∗
Log transformed.
Yoon et al. Medicine (2016) 95:36 Medicineassociation of NC with the development of CKD in female
subjects disappeared when further adjustment was made for
hs-CRP.
4. Discussion
Adiposity exerts a signiﬁcant role in the pathogenesis of various
diseases in overweight patients.[17,18] However, the impact of fat
tissues of different body parts on the renal outcome is not yet fully
investigated. In the current study, the associations between NCFigure 2. (A, B) Comparison of the mean value of NC according to incident CKD in
with incident CKD than in subjects without CKD. Each bar represents the mean a
groups. The high NC group showed signiﬁcantly higher incident CKD events tha
disease, NC=neck circumference.
4and cardiometabolic risk factors and the impact of NC on
incident CKD development were elucidated in a prospective
cohort of subjects without kidney disease. As a result, NC was
revealed to be a signiﬁcant independent predictor of incident
CKD events even after adjusting for confounding factors such as
other anthropometric parameters, traditional CKD risk factors,
and baseline eGFR.
Previous studies have demonstrated that fat tissues of different
body parts have differential roles in several cardiometabolic
complications.[5,6,10,19,20] AlthoughVAT, commonly representedboth sex groups. NC was signiﬁcantly higher in both male and female subjects
nd its standard error. (C) Comparison of the incident rate of CKD between NC
n the low NC group in both male and female subjects. CKD=chronic kidney
Table 3
Neck circumference is an independent predictor of incident chronic kidney disease.
Neck circumference, 1cm increase
Men Women
HR (95% CI) P HR (95% CI) P
Crude 1.082 (1.008–1.161) 0.029 1.137 (1.053–1.228) 0.001
Model 1
∗
1.073 (0.974–1.182) 0.153 1.180 (1.055–1.319) 0.004
Model 2† 1.047 (0.949–1.155) 0.358 1.173 (1.043–1.319) 0.008
Model 3‡ 0.989 (0.887–1.103) 0.841 1.159 (1.024–1.310) 0.019
CI= conﬁdence interval, eGFR=estimated glomerular ﬁltration rate, HR=hazard ratio.
∗
Model 1: adjusted for age, body mass index, and waist-to-hip ratio.
†Model 2: adjusted for model 1+alcohol consumption, smoking, exercise, history of hypertension, diabetes, and cardiovascular disease.
‡Model 3: adjusted for model 2+white blood cell, hemoglobin, fasting plasma glucose, triglyceride, and eGFR. Incident chronic kidney disease is deﬁned as new-onset decrease of eGFR to<60mL/min/1.73m2
or proteinuria that is higher than the trace level.
Yoon et al. Medicine (2016) 95:36 www.md-journal.comas the waist-to-hip ratio, was found to have relationships with
metabolic derangements, including insulin resistance,[21] type 2
diabetes,[22] hypertension,[23] and cardiovascular diseases,[24]
these associations between VAT and adverse metabolic compli-
cations were not strong enough.[25] Similarly, a close association
was shown between NC, a proxy of upper-body subcutaneous
fat, and metabolic complications.[10,14,26–30] Several recent
studies demonstrated that NC was a signiﬁcant risk factor for
type 2 diabetes, cardiovascular diseases, and ischemic stroke.[31]
In addition, a cross-sectional association between NC and eGFR
was found in a group of patients with or without CKD,
suggesting a possible pathogenic role of upper-body subcutane-
ous fat in the development of renal dysfunction.[29] In the present
study, we showed that NC was a signiﬁcant predictor of incident
CKD in a longitudinal analysis of subjects who did not have CKD
at baseline, which was consistent with the results of a previous
study. It should be noted that the impact of NC on CKD
development remained signiﬁcant even after adjusting for BMI
and waist-to-hip ratio. Meanwhile, lower-body subcutaneous fat
exerted protective effects on such adverse metabolic outcomes,
which were especially more prominent in women.[20,32,33]
The underlying mechanism of the association between NC and
the development of incident CKD is currently unclear. The level
of circulating NEFA was proposed as one of the factors linking
upper-body subcutaneous fat with cardiometabolic complica-
tions. Previous studies found that there were signiﬁcant
associations of NEFA levels with insulin resistance, hypertension,
and atherosclerosis. Upper-body subcutaneous fat and its
representative anthropometric parameter, NC, correlates with
circulating NEFA levels, and the clinical implications of NEFAFigure 3. Kaplan–Meier plots for CKD events in the low and high NC groups. (A) No
group in male subjects. (B) Female subjects in the high NC group showed a sig
circumference.
5are known to be more prominent in relatively obese sub-
jects.[11,34] Therefore, present study surmised that the association
of NC with renal outcomes would be more signiﬁcant in
individuals with higher BMI. In fact, the subjects with higher BMI
are more frequently accompanied with CKD risk factors such as
diabetes and hypertension. In addition, renal uptake of NEFAs by
the kidney proximal tubules induced tubulointerstitial inﬂam-
mation and ﬁbrosis, suggesting a causal relationship with various
renal diseases.[35] Furthermore, NEFAs affected vascular nitric
oxide production, promoting endothelial dysfunction, and
induced systemic inﬂammation, impairing vascular reactivity,
all of which were potential pathophysiologic mechanisms for
kidney damage. As upper-body subcutaneous fat was recently
demonstrated to be the main reservoir of circulating NEFAs, and
release from upper-body subcutaneous fat was predominantly
responsible for this surge in systemic NEFAs especially in obese
persons,[19] the excess in NEFA release could be one possible
mechanism for the association between NC and incident CKD
events observed in this study. Considering that NEFAs are freely
converted into triglycerides, the signiﬁcant positive correlation
between plasma triglyceride concentrations and NC in female
subjects in the current study might support this notion. In
addition, on the basis of the results of the current study revealing
that the signiﬁcant association of NC with incident CKD
development disappeared after adjusting for hs-CRP, it was
surmised that NEFAs contributed to adverse complications partly
through systemic inﬂammation. The possibility that these
coexisting risk factors could have played a role in increasing
risks of the incidence of CKD in individuals with larger NC could
not be ruled out. However, the fact that larger NC wassigniﬁcant difference in CKD incidence was found between the low and high NC
niﬁcantly higher incidence of CKD. CKD=chronic kidney disease, NC=neck
Yoon et al. Medicine (2016) 95:36 Medicinesigniﬁcantly associated with incident CKD development even
after adjustments were made for these confounding factors
suggests that NC could have an additive effect on renal function
decline over these traditional risk factors.
Another feasible factor linking NC with the development of
incident CKD can be obstructive sleep apnea syndrome, which
commonly occurs in persons with a large NC.[36] Obstructive
sleep apnea syndrome causes complete or incomplete upper
airway obstruction, often resulting in hypoxemia and an increase
in oxidative stress.[37] Accumulating evidence indicates that sleep
apnea is an independent risk factor for metabolic syndrome,[38]
hypertension,[39] and premature cardiovascular death.[40] Several
recent investigations also found that sleep apnea could mediate
renal damage.[41,42] In the present study, simple questionnaires
on obstructive sleep apnea symptoms were surveyed; however,
the prevalence of sleep apnea-related symptoms was too low and
there was no clear association between NC and incident CKD
events (data not shown). Nevertheless, as a thorough evaluation
for obstructive sleep apnea syndrome was not performed in this
study, further investigations on these issues are necessary.
Since the pathophysiologic consequence of adipose tissue is
known to differ between fat locations,[5,6,9,11,19,20] this study
intended to evaluate the effect of fat distribution on incidental
CKD risk rather than the effect of absolute adiposity amount.
Therefore, subjects that already had sufﬁcient amount of fat were
enrolled for investigation. In addition, upper-body subcutaneous
fat amount correlates with circulating NEFA levels,[19,34] and the
clinical implications of NEFA are known to bemore prominent in
relatively obese subjects.[43] Therefore, individuals with higher
BMI were investigated assuming that the association of NC with
renal outcome would be more signiﬁcant in this particular group.
However, subjects with higher BMI are more frequently
accompanied with CKD risk factors such as diabetes and
hypertension. The possibility that these coexisting risk factors
could have played a role in increasing risks of CKD incidence in
individuals with larger NC could not be ruled out. Nonetheless,
the fact that larger NC was signiﬁcantly associated with
incident CKD development even after adjustments were made
for these confounding factors suggests that NC could have
an additive effect on renal function decline over these traditional
risk factors.
Interestingly, the results of our study showed that NC was an
independent predictor of incident CKD development only in
female patients. A previous study demonstrated that obese men
stored much smaller amounts of NEFAs in the subcutaneous area
than obese women,[33] suggesting that the metabolic derange-
ments accompanied by increased subcutaneous fat might be
greater in women. Moreover, the Framingham Heart Study
revealed that the association between VAT and adverse
cardiovascular risk proﬁles were closer in women, implying a
greater vulnerability to fat-induced metabolic complications in
women.[5] On the basis of these ﬁndings, the differential impact of
NC on the development of incident CKD between male and
female subjects in the current study may in part be attributed to
the differences in lipid metabolism and the inﬂuence of fat tissues
between the sexes.
The present study has several limitations. First, as the study
subjects were all middle-aged Koreans, the signiﬁcant impact of
NC on incident CKD events may not be generalizable to other
populations. Second, although NC is considered a surrogate of
upper-body subcutaneous fat and is a simple anthropometric
measurement that is not affected by feeding or clothing, there is a
possibility of other causes leading to greater NC than fat6accumulation. Further investigations such as imaging studies on
quantiﬁcation of the upper-body subcutaneous adipose tissue are
mandatory to validate our study ﬁndings. Third, to verify that the
association between NC and incident CKD was attributed to
NEFAs, circulating NEFA levels should be determined; however,
these data were not available. Fourth, elevated levels of uric acid
are known to independently increase the risk for new-onset
kidney disease even in healthy volunteers.[44,45] Unfortunately,
circulating uric acid levels were not available in the present
cohort. Further investigations including serum uric acid levels as
factors inﬂuencing renal function should be needed. Last, the
cohort was followed biennially, and therefore the exact time of
CKD development could not be identiﬁed in detail.
In conclusion, NC is independently associated with the
development of incident CKD in overweight women, suggesting
that upper-body subcutaneous fat could play a relevant role in the
pathogenesis of renal disease in this population.Acknowledgments
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